Growth factors in critical illness: Regulation and therapeutic aspects

Robert A. Frost, Charles H. Lang

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


The erosion of lean body mass observed during catabolic illness is still a major cause of morbidity and mortality. The known anabolic actions of growth hormone and insulin-like growth factor-I have stimulated interest in the use of these agents to mitigate the loss of muscle protein after injury. This review summarizes advances in our understanding of how nutrition, hormones and proinflammatory cytokines regulate the somatotropic axis in health and disease, and recent studies involving the use of growth hormone or insulin-like growth factor-I in the treatment of critically ill patients.

Original languageEnglish (US)
Pages (from-to)195-204
Number of pages10
JournalCurrent opinion in clinical nutrition and metabolic care
Issue number2
StatePublished - Mar 1998

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Nutrition and Dietetics


Dive into the research topics of 'Growth factors in critical illness: Regulation and therapeutic aspects'. Together they form a unique fingerprint.

Cite this